Recent Finacing
Recent Raise
Prexa Pharmaceuticals is a Boston biotechnology company developing oral small-molecule monoamine mono- and dual-reuptake inhibitors, including lead candidate PRX-12251, for ADHD, depression and Parkinson’s disease.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
